Frequency Therapeutics
Founded Year
2015Stage
IPO | IPOTotal Raised
$216MDate of IPO
10/3/2019Market Cap
0.17BStock Price
4.75About Frequency Therapeutics
Frequency Therapeutics (NASDAQ: FREQ) is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases.
Missing: Frequency Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Frequency Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Frequency Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Frequency Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Frequency Therapeutics Patents
Frequency Therapeutics has filed 33 patents.
The 3 most popular patent topics include:
- Transcription factors
- Auditory system
- Audiology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/2/2017 | 3/1/2022 | Transcription factors, Stem cells, Auditory system, Cell biology, Ear | Grant |
Application Date | 3/2/2017 |
|---|---|
Grant Date | 3/1/2022 |
Title | |
Related Topics | Transcription factors, Stem cells, Auditory system, Cell biology, Ear |
Status | Grant |
Latest Frequency Therapeutics News
Dec 22, 2022
Experimental, early-stage drug aims to restore hearing Tens of thousands of Americans experience sudden hearing loss each year. Now, a biotech company called Frequency Therapeutics is hoping to be the first to make it to market with a drug it claims will use patients' own biology to restore what was lost. CBS News national correspondent Jericka Duncan reports.
Frequency Therapeutics Frequently Asked Questions (FAQ)
When was Frequency Therapeutics founded?
Frequency Therapeutics was founded in 2015.
Where is Frequency Therapeutics's headquarters?
Frequency Therapeutics's headquarters is located at 19 Presidential Way, Woburn.
What is Frequency Therapeutics's latest funding round?
Frequency Therapeutics's latest funding round is IPO.
How much did Frequency Therapeutics raise?
Frequency Therapeutics raised a total of $216M.
Who are the investors of Frequency Therapeutics?
Investors of Frequency Therapeutics include Cobro Ventures, Taiwania Capital, Axil Capital, Polaris Founders Capital, Mizuho Securities Principal Investment and 13 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.